<html><body><pre>
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2036 Introduced in House (IH)]

&lt;DOC&gt;






117th CONGRESS
  1st Session
                                H. R. 2036

 To direct the Secretary of Health and Human Services, in consultation 
with the Secretary of State, to formulate a strategy for entering into 
  agreements with foreign countries to develop and commercialize new 
          drugs to address pandemics, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 18, 2021

 Mr. Levin of California (for himself and Mr. Ferguson) introduced the 
 following bill; which was referred to the Committee on Foreign Affairs

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Health and Human Services, in consultation 
with the Secretary of State, to formulate a strategy for entering into 
  agreements with foreign countries to develop and commercialize new 
          drugs to address pandemics, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Saving Us from Pandemic Era 
Resistance by Building a Unified Global Strategy Act of 2021'' or the 
``SUPER BUGS Act of 2021''.

SEC. 2. INTERNATIONAL STRATEGY FOR DEVELOPMENT OF NEW DRUGS TO ADDRESS 
              PANDEMICS.

    (a) Strategy.--
            (1) In general.--Not later than 12 months after the date of 
        enactment of this Act, the Secretary of Health and Human 
        Services, in consultation with the Secretary of State, shall--
                    (A) formulate a strategy for entering into 
                agreements with foreign countries to help to develop 
                and commercialize (including through contracts with the 
                private sector) new drugs to address pandemics, 
                including antimicrobial drugs; and
                    (B) submit such strategy to the Congress.
            (2) Contents.--The strategy under paragraph (1) shall--
                    (A) provide for the harmonization of agreements and 
                contracts described in paragraph (1)(A);
                    (B) allow such countries to emphasize national or 
                regional issues of importance; and
                    (C) provide for collaboration among such countries, 
                so as to allocate joint or individual responsibility 
                across such countries for the development and 
                commercialization of particular drugs.
    (b) Agreements With Foreign Countries.--The Secretary of Health and 
Human Services, in consultation with the Secretary of State, shall seek 
to enter into agreements with foreign countries to implement the 
strategy under subsection (a).
    (c) Definition.--In this section, the term ``antimicrobial drug'' 
means--
            (1) an antibiotic drug, as defined in section 201(jj) of 
        the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(jj)); 
        or
            (2) a biological product, as defined in section 351(i) of 
        the Public Health Service Act (42 U.S.C. 262(i)), that exhibits 
        antimicrobial activity.
                                 &lt;all&gt;
</pre></body></html>
